COVID-19 and the Liver: visit our resource page for more information

Stand Up to NASH

In recent years, increasing age, obesity and diabetes have become more frequent in Canadians, affecting overall health, including that of the liver. With more than 90 therapies in development for NAFLD/NASH, there has never been a more important time to STAND UP to NASH.

Join CASL, CanNASH and Intercept for this new CPD activity, coming soon, to ensure that you and your colleagues – as well as any healthcare provider who treats patients with NAFLD and NASH – have the latest information regarding Surveillance, Treatment Approaches and New Diagnostic Updates concerning these diseases.